-
2
-
-
84979032808
-
-
World Health Organization. Health topic - Diabetes Mellitus, 2015. www.who.int/topics/diabetes-mellitus/en/.
-
(2015)
Health topic - Diabetes Mellitus
-
-
-
3
-
-
0029658824
-
Mechanisms of the glycaemic effects of sulfonylureas
-
Ashcroft FM. Mechanisms of the glycaemic effects of sulfonylureas. Horm Metab Res 1996; 28: 456-63. doi: 10.1055/s-2007-979837.
-
(1996)
Horm Metab Res
, vol.28
, pp. 456-463
-
-
Ashcroft, F.M.1
-
4
-
-
0035667081
-
Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide
-
Holstein A, Plaschke A, Egberts EH. Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. Diabetes Metab Res Rev 2001; 17: 467-73. doi: 10.1002/dmrr.235.
-
(2001)
Diabetes Metab Res Rev
, vol.17
, pp. 467-473
-
-
Holstein, A.1
Plaschke, A.2
Egberts, E.H.3
-
5
-
-
0029949970
-
Individual sulfonylureas and serious hypoglycemia in older people
-
Shorr RI, Ray WA, Daugherty JR, Griffin MR. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc 1996; 44: 751-5. doi: 10.1111/j.1532-5415.1996.tb03729.x.
-
(1996)
J Am Geriatr Soc
, vol.44
, pp. 751-755
-
-
Shorr, R.I.1
Ray, W.A.2
Daugherty, J.R.3
Griffin, M.R.4
-
6
-
-
0028019713
-
Glibenclamide vs gliclazide in type 2 diabetes of the elderly
-
Tessier D, Dawson K, Tétrault JP, Bravo G, Meneilly GS. Glibenclamide vs gliclazide in type 2 diabetes of the elderly. Diabet Med 1994; 11: 974-80. doi: 10.1111/j.1464-5491.1994.tb00256.x.
-
(1994)
Diabet Med
, vol.11
, pp. 974-980
-
-
Tessier, D.1
Dawson, K.2
Tétrault, J.P.3
Bravo, G.4
Meneilly, G.S.5
-
8
-
-
79958197888
-
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study
-
Schramm TK, Gislason GH, Vaag A, et al. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study. Eur Heart J 2011; 32: 1900-8. doi: 10.1093/eurheartj/ehr077.
-
(2011)
Eur Heart J
, vol.32
, pp. 1900-1908
-
-
Schramm, T.K.1
Gislason, G.H.2
Vaag, A.3
-
9
-
-
84892465849
-
The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: A systematic review and meta-analysis
-
Schopman JE, Simon AC, Hoefnagel SJ, Hoekstra JB, Scholten RJ, Holleman F. The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: A systematic review and meta-analysis. Diabetes Metab Res Rev 2014; 30: 11-22. doi: 10.1002/dmrr.2470.
-
(2014)
Diabetes Metab Res Rev
, vol.30
, pp. 11-22
-
-
Schopman, J.E.1
Simon, A.C.2
Hoefnagel, S.J.3
Hoekstra, J.B.4
Scholten, R.J.5
Holleman, F.6
-
10
-
-
0030852089
-
Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas
-
Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997; 157: 1681-6. doi: 10.1001/ archinte.1997.00440360095010.
-
(1997)
Arch Intern Med
, vol.157
, pp. 1681-1686
-
-
Shorr, R.I.1
Ray, W.A.2
Daugherty, J.R.3
Griffin, M.R.4
-
11
-
-
0032756168
-
Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas
-
Stahl M, Berger W. Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas. Diabet Med 1999; 16: 586-90. doi: 10.1046/j.1464-5491.1999.00110.x.
-
(1999)
Diabet Med
, vol.16
, pp. 586-590
-
-
Stahl, M.1
Berger, W.2
-
12
-
-
0041666594
-
DARTS/MEMO Collaboration. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: A population-based study of health service resource use
-
Leese GP, Wang J, Broomhall J, et al. DARTS/MEMO Collaboration. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: A population-based study of health service resource use. Diabetes Care 2003; 26: 1176-80. doi: 10.2337/ diacare.26.4.1176.
-
(2003)
Diabetes Care
, vol.26
, pp. 1176-1180
-
-
Leese, G.P.1
Wang, J.2
Broomhall, J.3
-
13
-
-
0030758711
-
Rates of hypoglycemia in users of sulfonylureas
-
Van Staa T, Abenhaim L, Monette J. Rates of hypoglycemia in users of sulfonylureas. J Clin Epidemiol 1997; 50: 735-41. doi: 10.1016/ S0895-4356(97)00024-3.
-
(1997)
J Clin Epidemiol
, vol.50
, pp. 735-741
-
-
Van Staa, T.1
Abenhaim, L.2
Monette, J.3
-
14
-
-
79958080038
-
Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: A population-based nested case-control study
-
Weir MA, Gomes T, Mamdani M, et al. Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: A population-based nested case-control study. Nephrol Dial Transplant 2011; 26: 1888-94. doi: 10.1093/ndt/gfq649.
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 1888-1894
-
-
Weir, M.A.1
Gomes, T.2
Mamdani, M.3
-
15
-
-
77955963898
-
Severe sulfonylurea-induced hypoglycemia: A problem of uncritical prescription and deficiencies of diabetes care in geriatric patients
-
Holstein A, Hammer C, Hahn M, Kulamadayil NS, Kovacs P. Severe sulfonylurea-induced hypoglycemia: A problem of uncritical prescription and deficiencies of diabetes care in geriatric patients. Expert Opin Drug Saf 2010; 9: 675-81. doi: 10.1517/14740338.2010.492777.
-
(2010)
Expert Opin Drug Saf
, vol.9
, pp. 675-681
-
-
Holstein, A.1
Hammer, C.2
Hahn, M.3
Kulamadayil, N.S.4
Kovacs, P.5
-
16
-
-
77951039382
-
Severe hypoglycaemia leading to hospital admission in type 2 diabetic patients aged 80 years or older
-
Greco D, Pisciotta M, Gambina F, Maggio F. Severe hypoglycaemia leading to hospital admission in type 2 diabetic patients aged 80 years or older. Exp Clin Endocrinol Diabetes 2010; 118: 215-9. doi: 10.1055/s-0029-1241823.
-
(2010)
Exp Clin Endocrinol Diabetes
, vol.118
, pp. 215-219
-
-
Greco, D.1
Pisciotta, M.2
Gambina, F.3
Maggio, F.4
-
17
-
-
84959475663
-
Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany/ Austria: How big is the problem? Which patients are at risk?
-
Schloot NC, Haupt A, Schutt M, et al. Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany/ Austria: How big is the problem? which patients are at risk? Diabetes Metab Res Rev 2016; 32: 316-24. doi: 10.1002/dmrr.2722.
-
(2016)
Diabetes Metab Res Rev
, vol.32
, pp. 316-324
-
-
Schloot, N.C.1
Haupt, A.2
Schutt, M.3
-
18
-
-
84939607655
-
Data resource profile: Clinical practice research datalink (CPRD
-
Herrett E, Gallagher AM, Bhaskaran K, et al. Data Resource Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol 2015; 44: 827-36. doi: 10.1093/ije/dyv098.
-
(2015)
Int J Epidemiol
, vol.44
, pp. 827-836
-
-
Herrett, E.1
Gallagher, A.M.2
Bhaskaran, K.3
-
19
-
-
72949102852
-
Validation and validity of diagnoses in the General Practice Research Database: A systematic review
-
Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: A systematic review. Br J Clin Pharmacol 2010; 69: 4-14. doi: 10.1111/j.1365-2125.2009.03537.x.
-
(2010)
Br J Clin Pharmacol
, vol.69
, pp. 4-14
-
-
Herrett, E.1
Thomas, S.L.2
Schoonen, W.M.3
Smeeth, L.4
Hall, A.J.5
-
20
-
-
0028580451
-
The quality of information recorded on a UK database of primary care records: A study of hospitalizations due to hypoglycemia and other conditions
-
Van Staa T, Abenhaim L. The quality of information recorded on a UK database of primary care records: A study of hospitalizations due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Saf 1994; 3: 15-21. doi: 10.1002/pds.2630030106.
-
(1994)
Pharmacoepidemiol Drug Saf
, vol.3
, pp. 15-21
-
-
Van Staa, T.1
Abenhaim, L.2
-
22
-
-
84905736258
-
Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK-A nested case-control analysis
-
Bruderer SG, Bodmer M, Jick SS, Bader G, Schlienger RG, Meier CR. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK-A nested case-control analysis. Diabetes Obes Metab 2014; 16: 801-11. doi: 10.1111/dom.12282.
-
(2014)
Diabetes Obes Metab
, vol.16
, pp. 801-811
-
-
Bruderer, S.G.1
Bodmer, M.2
Jick, S.S.3
Bader, G.4
Schlienger, R.G.5
Meier, C.R.6
-
23
-
-
33845267499
-
Beta blockers in the management of chronic kidney disease
-
Bakris GL, Hart P, Ritz E. Beta blockers in the management of chronic kidney disease. Kidney Int 2006; 70: 1905-13. doi: 10.1038/sj.ki.5001835.
-
(2006)
Kidney Int
, vol.70
, pp. 1905-1913
-
-
Bakris, G.L.1
Hart, P.2
Ritz, E.3
-
24
-
-
33751003491
-
Hypoglycemia in type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73
-
Wright AD, Cull CA, Macleod KM, Holman RR. UKPDS Group. Hypoglycemia in type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73. J Diabetes Complications 2006; 20: 395-401. doi: 10.1016/j.jdiacomp.2005.08.010.
-
(2006)
J Diabetes Complications
, vol.20
, pp. 395-401
-
-
Wright, A.D.1
Cull, C.A.2
Macleod, K.M.3
Holman, R.R.4
Ukpds, G.5
-
26
-
-
59249083934
-
Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: A nested case-control analysis
-
Bodmer M, Meier C, Krähenbühl S, Jick SS, Meier CR. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: A nested case-control analysis. Diabetes Care 2008; 31: 2086-91. doi: 10.2337/dc08-1171.
-
(2008)
Diabetes Care
, vol.31
, pp. 2086-2091
-
-
Bodmer, M.1
Meier, C.2
Krähenbühl, S.3
Jick, S.S.4
Meier, C.R.5
-
27
-
-
0029839173
-
Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells
-
Kramer W, Müller G, Geisen K. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells. Horm Metab Res 1996; 28: 464-8. doi: 10.1055/s-2007-979838.
-
(1996)
Horm Metab Res
, vol.28
, pp. 464-468
-
-
Kramer, W.1
Müller, G.2
Geisen, K.3
-
28
-
-
0028332660
-
Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics
-
Müller G, Hartz D, Pünter J, Okonomopulos R, Kramer W. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics. Biochim Biophys Acta 1994; 1191: 267-77. doi: 10.1016/0005-2736(94)90177-5.
-
(1994)
Biochim Biophys Acta
, vol.1191
, pp. 267-277
-
-
Müller, G.1
Hartz, D.2
Pünter, J.3
Okonomopulos, R.4
Kramer, W.5
-
29
-
-
0032835309
-
Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man
-
Raptis SA, Hatziagelaki E, Dimitriadis G, Draeger KE, Pfeiffer C, Raptis AE. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man. Exp Clin Endocrinol Diabetes 1999; 107: 350-5. doi: 10.1055/s-0029-1212125.
-
(1999)
Exp Clin Endocrinol Diabetes
, vol.107
, pp. 350-355
-
-
Raptis, S.A.1
Hatziagelaki, E.2
Dimitriadis, G.3
Draeger, K.E.4
Pfeiffer, C.5
Raptis, A.E.6
-
30
-
-
0029852409
-
Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): A double-blind comparison with glibenclamide
-
Draeger KE, Wernicke-Panten K, Lomp HJ, Schüler E, Rosskamp R. Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): A double-blind comparison with glibenclamide. Horm Metab Res 1996; 28: 419-25. doi: 10.1055/s-2007-979830.
-
(1996)
Horm Metab Res
, vol.28
, pp. 419-425
-
-
Draeger, K.E.1
Wernicke-Panten, K.2
Lomp, H.J.3
Schüler, E.4
Rosskamp, R.5
-
31
-
-
6944221200
-
Gliclazide modified release: Results of a 2-year study in patients with type 2 diabetes
-
Drouin P, Standl E, Diamicron MRSG. Diamicron MR Study Group. Gliclazide modified release: Results of a 2-year study in patients with type 2 diabetes. Diabetes Obes Metab 2004; 6: 414-21. doi: 10.1111/j.1462-8902.2004.00404.x.
-
(2004)
Diabetes Obes Metab
, vol.6
, pp. 414-421
-
-
Drouin, P.1
Standl, E.2
Diamicron, M.R.S.G.3
-
32
-
-
79956101975
-
2009 Ramadan Study Group. Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: A five-country observational study
-
Aravind SR, Al Tayeb K, Ismail SB, et al. 2009 Ramadan Study Group. Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: A five-country observational study. Curr Med Res Opin 2011; 27: 1237-42. doi: 10.1185/03007995.2011.578245.
-
(2011)
Curr Med Res Opin
, vol.27
, pp. 1237-1242
-
-
Aravind, S.R.1
Al Tayeb, K.2
Ismail, S.B.3
-
34
-
-
84882932426
-
Avoiding hypoglycemia: A key to success for glucoselowering therapy in type 2 diabetes
-
Ahrén B. Avoiding hypoglycemia: A key to success for glucoselowering therapy in type 2 diabetes. Vasc Health Risk Manag 2013; 9: 155-63. doi: 10.2147/VHRM.S33934.
-
(2013)
Vasc Health Risk Manag
, vol.9
, pp. 155-163
-
-
Ahrén, B.1
-
35
-
-
84910134162
-
Identifying risk factors for severe hypoglycemia in hospitalized patients with diabetes
-
Dendy JA, Chockalingam V, Tirumalasetty NN, et al. Identifying risk factors for severe hypoglycemia in hospitalized patients with diabetes. Endocr Pract 2014; 20: 1051-6. doi: 10.4158/EP13467.OR.
-
(2014)
Endocr Pract
, vol.20
, pp. 1051-1056
-
-
Dendy, J.A.1
Chockalingam, V.2
Tirumalasetty, N.N.3
|